Organisation paid for research Program year 2025 Source: CMS Open Payments

Q Squared Solutions

Neither a doctor nor a teaching hospital

Research payments

$2,278,311

105 payments

Through program year 2025, Q Squared Solutions is reported as receiving $2,278,311 in research payments, across 105 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$95,806	6
2024	Research	$718,932	21
2023	Research	$750,987	20
2022	Research	$124,532	14
2021	Research	$63,862	11
2020	Research	$321,177	21
2019	Research	$203,015	12

Breakdown

Who paid Research payments · program years 2019–2025

Ventana Medical Systems, Inc. $1,109,995 80 payments
E.R. Squibb & Sons, L.L.C. $1,073,662 23 payments
Becton, Dickinson and Company $89,241 1 payment
Celgene Corporation $5,413 1 payment

Studies the money was for Research payments · program years 2019–2025

Rd006144 $282,633 16 payments
SAD/MAD/FE/FB - A Phase 1, Randomized, Multi-Part, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of BMS-986421 in Healthy Participants $203,354 2 payments
A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants $184,564 2 payments
FIH Study with TYK2 #4 - A Double-blind, Placebo-controlled, Randomized, Single and Multiple Ascending Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986322 in Healthy Participants Including an Open-label Assessment of Food and pH $166,497 1 payment
SAD Cohorts - A Phase 1 Randomized, Double-blind, Placebo-controlled, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single, Ascending Doses of BMS-986447 in Healthy Adult Participants $159,826 1 payment
Rd003315 $142,242 12 payments
A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986447 in Healthy Participants $122,685 2 payments
Rd003531 $108,640 6 payments
Rd005287 $107,891 3 payments
Viper LT HPV Longitudinal $89,241 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.